Journal for ImmunoTherapy of Cancer (Nov 2020)

287 Safety and antitumor activity of indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor KHK2455 in combination with anti-CCR4 monoclonal antibody mogamulizumab in patients with advanced solid tumors

  • Yi Liu,
  • Capucine Baldini,
  • Jameel Muzaffar,
  • David Hong,
  • Olivier Rixe,
  • Christophe Massard,
  • Timothy Yap,
  • Solmaz Sahebjam,
  • Ursa Brown-Glaberman,
  • Andreea Varga,
  • Sergey Efuni,
  • Barbara Kapelan,
  • Eniola Ogunmefun,
  • Tomonori Tayama,
  • Henry Zhao,
  • Denis Healy,
  • Robert Latek,
  • Daisuke Nakashima,
  • Emrullah Yilmaz

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0287
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.